deltatrials
Completed PHASE4 INTERVENTIONAL 2-arm NCT00718406

Pain Relief of Metoprolol Versus Metoprolol Plus Morphine in Acute Chest Pain

Sponsor: AstraZeneca

Conditions Acute Coronary Syndromes
Interventions Metoprolol metoprolol plus morphine
Updated 7 times since 2017 Last updated: Jul 16, 2008
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT00718406, this PHASE4 trial focuses on Acute Coronary Syndromes and remains completed. Sponsored by AstraZeneca, it has been updated 7 times since 2026, reflecting limited change activity. This study contributes longitudinal data to the cardiovascular research landscape.

Status Flow

~Jan 2017 – ~Jan 2021 · 48 months · monthly snapshotCompleted~Jan 2021 – ~Jul 2024 · 42 months · monthly snapshotCompleted~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshotCompleted~Sep 2024 – ~Feb 2025 · 5 months · monthly snapshotCompleted~Feb 2025 – ~Mar 2025 · 28 days · monthly snapshotCompleted~Mar 2025 – ~Sep 2025 · 6 months · monthly snapshotCompleted~Sep 2025 – present · 10 months · monthly snapshotCompleted

Change History

7 versions recorded

  1. Sep 2025 — Present [monthly]

    Completed PHASE4

  2. Mar 2025 — Sep 2025 [monthly]

    Completed PHASE4

  3. Feb 2025 — Mar 2025 [monthly]

    Completed PHASE4

  4. Sep 2024 — Feb 2025 [monthly]

    Completed PHASE4

  5. Jul 2024 — Sep 2024 [monthly]

    Completed PHASE4

▶ Show 2 earlier versions

  1. Jan 2021 — Jul 2024 [monthly]

    Completed PHASE4

  2. Jan 2017 — Jan 2021 [monthly]

    Completed PHASE4

    First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • AstraZeneca
  • Sahlgrenska University Hospital
Data source: Sahlgrenska University Hospital

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations